Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 31

Trial Status

Completed1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT03969121Phase 3Completed
Neoadjuvant Hormonal Therapy Plus Palbociclib in Operable, Hormone Sensitive and HER2-Negative Primary Breast Cancer
Breast Cancer FemaleHormone Receptor Positive Malignant Neoplasm of Breast
PrincipalinvestigatorStart date: 2019-07-16

Research Network

Collaboration Network

3 collaborators·3 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Cancer Institute Hospital of JFCR, Department Director, Breast Surgical Oncology Department

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Alison Stopeck, MD

Stony Brook University

Moderately Similar
4 trials

Shared therapeutic areas:

Breast Cancer FemaleHormone Receptor Positive Malignant Neoplasm of Breast
Similarity Score30%

Masakazu Toi, MD,PhD

Kyoto University, Professor of Breast Surgery Department

Related
1 trials

Shared therapeutic areas:

Breast Cancer FemaleHormone Receptor Positive Malignant Neoplasm of Breast

Worked with same sponsors:

Kyoto Breast Cancer Research NetworkPfizer
Collaborated on 1 trial
Similarity Score24%

Louis WC Chow, MD,PhD

Organisation for Oncology and Translational Research (OOTR)

Related
1 trials

Shared therapeutic areas:

Breast Cancer FemaleHormone Receptor Positive Malignant Neoplasm of Breast

Worked with same sponsors:

Kyoto Breast Cancer Research NetworkPfizer
Collaborated on 1 trial
Similarity Score24%

Jennifer Brunet, PhD

University of Ottawa

Related
4 trials

Shared therapeutic areas:

Breast Cancer Female
Similarity Score15%

Jean Olivier Arnaud, Director

Assistance Publique Hôpitaux de Marseille

Related
4 trials

Shared therapeutic areas:

Breast Cancer Female
Similarity Score15%

Alastair Thompson, MD

Baylor College of Medicine

Related
3 trials

Shared therapeutic areas:

Breast Cancer Female
Similarity Score15%

Laurence VANLEMMENS, MD

Centre Oscar Lambret

Related
4 trials

Shared therapeutic areas:

Breast Cancer Female
Similarity Score15%

Irene Cantarero Villanueva, PhD

Universidad de Granada

Related
3 trials

Shared therapeutic areas:

Breast Cancer Female
Similarity Score15%

Glenn Lesser, MD

Wake Forest University Health Sciences

Related
10 trials

Shared therapeutic areas:

Breast Cancer Female
Similarity Score15%

Emma Hansson, PhD

Göteborg University

Related
3 trials

Shared therapeutic areas:

Breast Cancer Female
Similarity Score15%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT03969121Phase 3PrincipalInvestigator

Neoadjuvant Hormonal Therapy Plus Palbociclib in Operable, Hormone Sensitive and HER2-Negative Primary Breast Cancer

Breast Cancer FemaleHormone Receptor Positive Malignant Neoplasm of Breast
Completed

All 1 trials loaded